TR200200532T2 - Su dağıtım sistemiyle hedef bir hayvana suda çözünmeyen ilacın uygulanması için veteriner formülasyon. - Google Patents

Su dağıtım sistemiyle hedef bir hayvana suda çözünmeyen ilacın uygulanması için veteriner formülasyon.

Info

Publication number
TR200200532T2
TR200200532T2 TR2002/00532T TR200200532T TR200200532T2 TR 200200532 T2 TR200200532 T2 TR 200200532T2 TR 2002/00532 T TR2002/00532 T TR 2002/00532T TR 200200532 T TR200200532 T TR 200200532T TR 200200532 T2 TR200200532 T2 TR 200200532T2
Authority
TR
Turkey
Prior art keywords
water
distribution system
water distribution
application
target animal
Prior art date
Application number
TR2002/00532T
Other languages
English (en)
Inventor
Frank Ekhart Peter
Van Wandelen Mario
Matthijs Jetten Jan
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200200532T2 publication Critical patent/TR200200532T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus endüstriyel ölçekte kolaylikla üretilebilen ve bir veya daha fazla suda çözünmeyen veteriner ilacinin su dagitim sistemi yoluyla tekrar edilebilir ve etkin uygulamasini saglayan bir süspoemülsiyon formülasyonunun hazirlanmasi için olan bir yöntem ile ilgilidir. Ince ögütülmüs formda olan suda çözünmeyen veteriner ilaci bu sistemin bir su fazi içinde homojenlestirilme islemi ardindan bir su ile karismaz sivi içinde dagitilir.Dengeli bir formülasyonun hazirlanmasini kolaylastirmak için emülsiflestiriciler,kalinlastiricilar,anti-oksidanlar ve anti-mikrobiyaller gibi bir veya daha fazla dengeleyici madde kullanilabilir.Olusan süspoemülsiyon mükemmel derecede uzun süreli depolama dengesi ve bir tank içinde seyreltildikten sonra ve su dagitim sistemindeki tüm kotarilma ve tasinma sirasinda iyi bir kullanim sirasinda denge gösterir.
TR2002/00532T 1999-09-03 2000-08-28 Su dağıtım sistemiyle hedef bir hayvana suda çözünmeyen ilacın uygulanması için veteriner formülasyon. TR200200532T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99202876 1999-09-03

Publications (1)

Publication Number Publication Date
TR200200532T2 true TR200200532T2 (tr) 2002-07-22

Family

ID=8240608

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00532T TR200200532T2 (tr) 1999-09-03 2000-08-28 Su dağıtım sistemiyle hedef bir hayvana suda çözünmeyen ilacın uygulanması için veteriner formülasyon.

Country Status (35)

Country Link
US (1) US9040571B2 (tr)
EP (1) EP1214052B1 (tr)
JP (1) JP4754139B2 (tr)
KR (1) KR100702540B1 (tr)
CN (1) CN1165289C (tr)
AR (1) AR025470A1 (tr)
AT (1) ATE273000T1 (tr)
AU (1) AU775216B2 (tr)
BG (1) BG65673B1 (tr)
BR (1) BR0013754A (tr)
CA (1) CA2383164C (tr)
CZ (1) CZ301938B6 (tr)
DE (1) DE60012947T2 (tr)
EA (1) EA004785B1 (tr)
EE (1) EE05052B1 (tr)
ES (1) ES2226914T3 (tr)
HK (1) HK1049628B (tr)
HR (1) HRP20020173B1 (tr)
HU (1) HU229311B1 (tr)
IL (2) IL148438A0 (tr)
MA (1) MA25432A1 (tr)
ME (1) ME00132B (tr)
MX (1) MXPA02002360A (tr)
MY (1) MY128072A (tr)
NZ (1) NZ517024A (tr)
PL (1) PL201484B1 (tr)
PT (1) PT1214052E (tr)
RS (1) RS50341B (tr)
SI (1) SI1214052T1 (tr)
SK (1) SK285825B6 (tr)
TR (1) TR200200532T2 (tr)
TW (1) TWI234468B (tr)
UA (1) UA72933C2 (tr)
WO (1) WO2001017504A1 (tr)
ZA (1) ZA200201708B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
ES2344275T3 (es) 2005-07-28 2010-08-23 Intervet International Bv Nuevos (tio) carbamatos de benzimidazol con actividad antiparasitaria y sintesis de ellos.
PL2037914T3 (pl) * 2006-06-14 2014-04-30 Intervet Int Bv Zawiesina zawierająca karbaminian benzoimidazolu i polisorbat
AR077320A1 (es) 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
RU2522267C2 (ru) * 2012-08-28 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
RU2522229C1 (ru) * 2013-03-26 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Юго-Западный государственный университет" (ЮЗ ГУ) Способ инкапсуляции фенбендазола
RU2545742C2 (ru) * 2013-07-23 2015-04-10 Александр Александрович Кролевец Способ инкапсуляции лактобифадола
RU2555782C1 (ru) * 2014-03-03 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в конжаковой камеди в гексане
RU2558084C1 (ru) * 2014-03-18 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в каррагинане
RU2555055C1 (ru) * 2014-03-18 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в ксантановой камеди
RU2557941C1 (ru) * 2014-03-20 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в альгинате натрия
RU2554759C1 (ru) * 2014-04-07 2015-06-27 Александр Александрович Кролевец Способ получения нанокапсул лозартана калия
US20190083629A1 (en) * 2016-04-29 2019-03-21 Rousselot B.V. Protein based excipient for active pharmaceutical ingredients
CN110151692A (zh) * 2019-06-21 2019-08-23 石家庄九鼎动物药业有限公司 一种兽用抗寄生虫药物阿苯达唑混悬液制备方法
CN110693830B (zh) * 2019-10-10 2021-09-17 华中农业大学 一种兽用奥芬达唑纳米混悬液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US5538989A (en) * 1993-11-10 1996-07-23 Hoechst-Roussel Agri-Vet Company Fenbendazole formulations
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions

Also Published As

Publication number Publication date
ES2226914T3 (es) 2005-04-01
SK285825B6 (sk) 2007-09-06
EE05052B1 (et) 2008-08-15
US9040571B2 (en) 2015-05-26
MA25432A1 (fr) 2002-04-01
HUP0202686A2 (hu) 2004-05-28
PL201484B1 (pl) 2009-04-30
WO2001017504A1 (en) 2001-03-15
MEP9108A (en) 2010-06-10
RS50341B (sr) 2009-11-10
CA2383164A1 (en) 2001-03-15
HK1049628A1 (en) 2003-05-23
CZ301938B6 (cs) 2010-08-04
CZ2002630A3 (cs) 2002-09-11
AR025470A1 (es) 2002-11-27
HRP20020173B1 (en) 2005-02-28
CN1165289C (zh) 2004-09-08
UA72933C2 (uk) 2005-05-16
EA004785B1 (ru) 2004-08-26
EA200200325A1 (ru) 2002-08-29
IL148438A (en) 2006-12-10
CN1372462A (zh) 2002-10-02
ZA200201708B (en) 2003-08-27
PT1214052E (pt) 2004-12-31
SK2642002A3 (en) 2002-12-03
BG106448A (en) 2002-09-30
JP2003508482A (ja) 2003-03-04
KR20020063844A (ko) 2002-08-05
EP1214052A1 (en) 2002-06-19
AU7322900A (en) 2001-04-10
ATE273000T1 (de) 2004-08-15
AU775216B2 (en) 2004-07-22
MXPA02002360A (es) 2002-07-30
JP4754139B2 (ja) 2011-08-24
BR0013754A (pt) 2002-05-21
HK1049628B (zh) 2005-05-13
HU229311B1 (en) 2013-10-28
IL148438A0 (en) 2002-09-12
SI1214052T1 (en) 2005-02-28
MY128072A (en) 2007-01-31
EE200200094A (et) 2003-04-15
KR100702540B1 (ko) 2007-04-04
HUP0202686A3 (en) 2004-06-28
HRP20020173A2 (en) 2004-04-30
TWI234468B (en) 2005-06-21
CA2383164C (en) 2008-07-08
DE60012947T2 (de) 2005-08-25
PL353481A1 (en) 2003-11-17
BG65673B1 (bg) 2009-06-30
ME00132B (me) 2010-10-10
US20090062362A1 (en) 2009-03-05
NZ517024A (en) 2003-05-30
YU14302A (sh) 2004-11-25
EP1214052B1 (en) 2004-08-11
DE60012947D1 (de) 2004-09-16

Similar Documents

Publication Publication Date Title
TR200200532T2 (tr) Su dağıtım sistemiyle hedef bir hayvana suda çözünmeyen ilacın uygulanması için veteriner formülasyon.
Camacho-Encina et al. Cellular senescence, mitochondrial dysfunction, and their link to cardiovascular disease
Kearney et al. Design and development of liquid drug reservoirs for microneedle delivery of poorly soluble drug molecules
ES2132663T3 (es) Puesto de cebo para liberacion de liquido en dos etapas.
MA62173B1 (fr) Formulations d'anticorps anti-rankl humains et leurs procédés d'utilisation
Itabashi et al. Mechanical impulses can control metaphase progression in a mammalian cell
Chen et al. Protective effects of isorhamnetin on apoptosis and inflammation in TNF-α-induced HUVECs injury
BR112016026879A8 (pt) composição farmacêutica aquosa, seu uso, e dispositivo de distribuição de fármaco
BRPI0212028B1 (pt) sistema terapêutico transdérmico (tts) e seu processo de produção
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
Soler et al. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization
Rizvi et al. Low-dose γ-rays modify CD4+ T cell signalling response to simulated solar particle event protons in a mouse model
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
Sato Consideration for future in vitro BBB models-technical development to investigate the drug delivery to the CNS
Takeda On the biological functions of tissue mast cells in the salivary gland
Sarango-Granda et al. The Impact of Vehicle Occlusivity on Skin Delivery and Activity of a Janus Kinase Inhibitor: Comparison of Oil-Based Formulations
Nielsen et al. Selective use of corifollitropin for controlled ovarian stimulation for IVF in patients with low anti-Müllerian hormone
Li et al. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier
Pilinskaia Evaluation of the cytogenetic effect of the herbicide treflan and of a number of its metabolites on mammalian somatic cells
Iacobucci Swedish company launches NHS partnership in bid to enter GP app market
Lupker Residual host cell protein from continuous cell lines. Effect on the safety of protein pharmaceuticals
Shi et al. Study of antioxidant effect of cannabinoid receptor type 2 agonist on rat hepatic stellate cell line
Nováček et al. Prospects and scope of anthropological investigation of cremated human remains: Workshop of the Workgroup Palaeoanthropology and Physical Anthropology of the Society for Anthropology on the investigation of cremated human remains, 12th and 13th April 2019 in Weimar, Germany
Sánchez Miranda et al. Study of the impact of environmental pictures on emotional aspects
Yurttas et al. Retraction Note: Yurttas V et al. Prognostic factors for graft success in tympanoplasty with mastoidectomy. ENT Updates 2015; 5: 72-75